Inactive Instrument
TxCell Share Price CBOE
Stocks
0QTN
FR0010127662
Biotechnology & Medical Research
|
End-of-day quote
CBOE
|
||
| - EUR | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Sandrine Boulet
COO | Chief Operating Officer | 50 | - |
| Corporate Officer/Principal | - | - | |
Bernard Malissen
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Duncan Mckay
CHM | Chairman | - | 12/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.25% | -1.36% | +44.08% | +102.76% | 6.82TCr | |
| +0.42% | -3.58% | +31.58% | +75.23% | 6.22TCr | |
| +0.62% | +0.47% | -12.78% | +384.69% | 2.78TCr | |
| -1.05% | -4.43% | +30.56% | +10.07% | 2.49TCr | |
| +1.15% | -6.30% | -4.55% | -19.75% | 2.42TCr | |
| +0.17% | -3.60% | +14.58% | -19.48% | 1.94TCr | |
| -1.86% | -2.22% | +202.03% | +353.89% | 1.73TCr | |
| -1.94% | -4.94% | -5.29% | +495.65% | 1.45TCr | |
| -4.54% | -2.88% | +52.33% | +159.75% | 1.42TCr | |
| Average | -0.75% | -3.30% | +39.17% | +171.42% | 3.03TCr | |
| Weighted average by Cap. | -0.27% | -3.10% | +35.61% | +136.93% |
Employees
-
- Stock Market
- Stocks
- TXCL Stock
- 0QTN Stock
Select your edition
All financial news and data tailored to specific country editions
